Although a relatively rare phenomenon, lymphocytic hypophysitis can represent a difficult diagnostic and therapeutic challenge. This condition was initially thought to be an autoimmune phenomenon ...

Please provide your email address to receive an email when new articles are posted on . A 34-year-old woman was referred for evaluation of a pituitary mass. The patient reported that she was well ...

Background. A 29-year-old man was referred to a multidisciplinary pituitary clinic with a 3.5-year history of central diabetes insipidus, initially presumed to be idiopathic based on a normal MRI scan ...

BOSTON — All cancer patients receiving treatment with the immune checkpoint inhibitor ipilimumab (Yervoy, Bristol-Myers Squibb) should be closely monitored for signs and symptoms of hypophysitis, new ...

The coronavirus disease 2019 (COVID-19) pandemic brought about by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has adversely impacted public health worldwide, leading to millions of ...

Please provide your email address to receive an email when new articles are posted on . High-dose glucocorticoid therapy failed to benefit patients with melanoma who developed hypophysitis following ...

BOSTON -- Among patients treated with the CTLA-4 inhibitor ipilimumab, clinical factors predicting ipilimumab-induced hypophysitis (IH) are still undetermined, researchers reported here. In a cohort ...

Effect of G-CSF primary prophylaxis on prevention of severe neutropenia in FOLFIRINOX therapy: A systematic review and a meta-analysis. Guard-02: Safety and efficacy of prophylactic use of novel ...